Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

iThemba Pharmaceuticals (Pty) Ltd

iThemba Pharmaceuticals (Pty) Ltd is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.

View iThemba Pharmaceuticals (Pty) Ltd on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Chemical and Compound Analysis

  • Compound Integrity Analyze the identity and purity of small molecule drug candidates.

Discovery Chemistry

  • Compound Purchase Buy compounds, building blocks or compound libraries.
  • Compound Synthesis Synthesize small molecule candidates for use in hit followup, lead optimization and medicinal chemistry.

Service areas:

Chemistry

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • South Africa City of Johannesburg 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

iThemba, which means 'hope' in Zulu, is a research based drug discovery company based in Modderfontein, South Africa. The company mission is to champion world-class, drug discovery and development of new treatments for neglected infectious diseases including HIV/Aids, Malaria and Tuberculosis (TB). The company has developed a strong foundation in synthetic organic, natural product and medicinal chemistry; it has core staff with diverse multinational experience and is well-supported through several world renowned pharmaceutical experts, who sit on its scientific advisory and shareholder...

Show the full description

iThemba, which means 'hope' in Zulu, is a research based drug discovery company based in Modderfontein, South Africa. The company mission is to champion world-class, drug discovery and development of new treatments for neglected infectious diseases including HIV/Aids, Malaria and Tuberculosis (TB).

The company has developed a strong foundation in synthetic organic, natural product and medicinal chemistry; it has core staff with diverse multinational experience and is well-supported through several world renowned pharmaceutical experts, who sit on its scientific advisory and shareholder boards.

iThemba funds the drug discovery activities through their chemistry services business, and are looking to attract FTE and custom synthesis projects. The company has state of the art facilities for synthesis and analysis and has validated most modern synthetic chemistry techniques in-house. The company offers the following services

  • Synthesis on milligram to multigram scales on single or multistep synthetic routes
  • Follow established synthetic routes, design new synthetic routes or trouble shoot existing routes.
  • Provide custom intermediates, reagents and analogues
  • Hit-to Lead chemistry
  • Synthesis of lead discovery libraries consisting of highly pure single compounds
  • Hit validation
  • Pharmaceutically relevant chemical intermediates
Website
www.ithembapharma.com

Source: Scientist.com supplier network, written by the supplier

Get the iThemba Pharmaceuticals (Pty) Ltd report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with iThemba Pharmaceuticals (Pty) Ltd on Scientist.com

For prices, more details, or to contact iThemba Pharmaceuticals (Pty) Ltd, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.